Vaughn Hoblet
Nurse Practitioner · Toledo, OHNPI 1205277464
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,511 of the $18,817 with a category attached, or 66.5%. 33 manufacturers reported payments, led by Dexcom, Inc. at 38.3% of the total. 2025 is the largest year on record at $7,569, 4.1 times the $1,837 reported in 2021. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 676 payments — averaging $27.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$7K
- Novo Nordisk$2K
- AstraZeneca$2K
- AbbVie$1K
- Boehringer Ingelheim$936
- Bayer$896
- plus $5K from 27 others
What the payments were for
- Speaking & faculty fees$5,70030%
- Travel & lodging$5823%
- Food & beverage$12,51166%
- Education$240%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 51 | $7,214 |
| Novo Nordisk | 90 | $1,647 |
| AstraZeneca | 30 | $1,506 |
| AbbVie | 77 | $1,238 |
| Boehringer Ingelheim | 47 | $936 |
| Bayer | 51 | $896 |
| Pfizer | 61 | $885 |
| GSK | 38 | $774 |
| Lilly USA, LLC | 61 | $750 |
| Merck | 40 | $728 |
| Exact Sciences | 22 | $373 |
| Novartis | 15 | $257 |
| Biohaven Pharmaceuticals, Inc. | 14 | $214 |
| Mylan Specialty L.p. | 9 | $184 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $168 |
| Biohaven Pharmaceutical Holding Company Ltd. | 18 | $168 |
| Otsuka America Pharmaceutical, Inc. | 7 | $128 |
| Abbott | 6 | $122 |
| Lundbeck LLC | 4 | $100 |
| Johnson & Johnson | 3 | $98 |
| Phadia US Inc. | 5 | $87 |
| Teva Pharmaceuticals USA, Inc. | 4 | $60 |
| Corcept Therapeutics | 3 | $59 |
| Astellas Pharma US Inc | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Shield Therapeutics Inc | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Viatris Specialty LLC | 1 | $21 |
| Amgen | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Grifols USA, LLC | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G7 GSS (161)$6,380
- DEXCOM STELO GLUCOSE BIOSENSOR$5,630
- BREZTRI$874
- FARXIGA$852
- AIRSUPRA$552
- AREXVY$250
- Ozempic$125
- RYBELSUS$125
- Kerendia$125
How this compares
$18,817 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 147 | $133,364 |
| OzempicSemaglutide | 96 | $130,917 |
| RybelsusSemaglutide | 37 | $68,357 |
| EliquisApixaban | 56 | $65,642 |
| KerendiaFinerenone | 47 | $53,793 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 76 | $53,528 |
| TrulicityDulaglutide | 40 | $53,277 |
| JardianceEmpagliflozin | 33 | $40,001 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 56 | $35,057 |
| CreonLipase/Protease/Amylase | 16 | $34,257 |
| VraylarCariprazine Hcl | 15 | $29,761 |
| EntrestoSacubitril/Valsartan | 28 | $23,244 |
| MounjaroTirzepatide | 21 | $22,857 |
| Tresiba Flextouch U-200Insulin Degludec | 22 | $15,660 |
| LinzessLinaclotide | 20 | $12,589 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,647 | $199,274133 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,506 | $173,653227 claims |
| AbbVieCreon, Vraylar, Linzess | $1,238 | $76,60751 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $750 | $76,13461 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta | $774 | $72,320120 claims |
| PfizerEliquis | $885 | $65,64256 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat | $936 | $62,85670 claims |
| BayerKerendia | $896 | $53,79347 claims |
| NovartisEntresto | $257 | $23,24428 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Other nurse practitioner in Toledo
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.